CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Barclays Adjusts Biogen Price Target to $200 From $185, Maintains Equalweight Rating

Neutral
AI Analysis

Summary

Barclays increased its price target for Biogen from $185 to $200 while maintaining an Equalweight rating.

Importance:2/10
Sentiment:
0.10
analyst_updateprice_targetrating
Related Companies

Read the original article

Published by yahoo_finance on July 28, 2026 11:38 AM

Read Original